The importance of timely detection of sleep disorders as an independent risk factor for the development of cardiovascular diseases
AbstractOne of the main strategic directions in the prevention of the cardiovascular diseases and their complications development is the timely identification and correction of well-known modifiable risk factors such as physical inactivity, unhealthy diet, smoking, excessive alcohol consumption, obesity, arterial hypertension, psychosocial factors. Recent studies have shown a significant impact of sleep disorders on the risk of developing cardiovascular diseases, their complications, as well as the peculiarities of their course. Several researchers consider sleep disorders such as insomnia and obstructive sleep apnea syndrome as an independent risk factor for cardiovascular diseases. Despite the extremely high prevalence of these conditions in the population, their detectability remains at an extremely low level. The development of outpatient diagnosis of sleep disorders makes the detection of apnea more accessible, unlike the era of polysomnological research.
Timely diagnosis and treatment of sleep apnea and insomnia can minimize the risks of developing cardiovascular diseases and complications and, accordingly, increase the medical, social and economic effectiveness of the treatment.
Keywords:cardiovascular diseases; risk factors; insomnia; obstructive sleep apnea syndrome
Funding. The study had no sponsor support.
Conflict of interest. The author declares no conflict of interest.
For citation: Plemyannikova E.V. The importance of timely detection of sleep disorders as an independent risk factor for the development of cardiovascular diseases. The intensity of thrombinogenesis and the activity of the protein C system in patients with coronary artery disease before and after endovascular revascularization. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training]. 2023; 11 (4): 29–35. DOI: https://doi.org/10.33029/2309-1908-2023-11-4-29-35 (in Russian)
References
1. Timmis A., Vardas P., Townsend N., et al. Eur Heart J. 2022; 43 (8): 716–99. DOI: https://doi.org/10.1093/eurheartj/ehab892
2. Russian statistical yearbook. Statistical collection. Moscow: Rosstat, 2021. 692 p. DOI: https://rosstat.gov.ru/folder/210/document/12994 (in Russian)
3. Vishnevsky A., Andreev E., Timonin S. Mortality from cardiovascular diseases and life expectancy in Russia. Demogrificheskoe obozrinie [Demographic Review]. 2016; 3 (1): 6–34. (in Russian)
4. Cardiovascular prevention 2022. Russian national guidelines. Moscow, 2022. 357 p. DOI: https://scardio.ru/content/Guidelines/Kardiovascular_profilaktika_2022.pdf (in Russian)
5. Pogosova N., Oganov R., Saner H., et al. Potential and limitations of health policy to improve coronary heart disease prevention and to reduce the burden of disease: A Russian experience // Eur. J. Prev. Cardiol. 2018; 25: 1725–34. DOI: https://doi.org/10.1177/2047487318768030
6. Kalinina A.M., Ipatov P.V., Kushunina D.V., Egorov V.A., Drozdova L. Yu., Boytsov S.A. Results of circulatory disease detection during prophylactic medical examination of the adult population: the first two years’ experience. Terapevticheskii arkhiv [Therapeutic Archive]. 2016; 88 (1): 46–52. (in Russian)
7. Boytsov S.A., Deev A.D., Shalnova S.A. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis. Terapevticheskii Arkhiv [Therapeutic Archive]. 2017; 89 (1): 5–13. DOI: https://doi.org/10.17116/terarkh20178915-13 (in Russian)
8. Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. X-ray endovascular diagnosis and treatment of heart and vascular diseases in the Russian Federation. Spetsial’nyy vypusk zhurnala “Endovaskulyarnaya khirurgiya” [Special issue of the journal “Endovascular Surgery”]. 2021; 8: 5–248. DOI: https://doi.org/10.24183/2409-4080-2021-8S-S5-S248 (in Russian)
9. Alekyan B.G., Boytsov S.A., Manoshkina E.M., Ganyukov V.I. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016–2020. Kardiologiia [Cardiology]. 2021; 61 (12): 4–15. DOI: https://doi.org/10.18087/cardio.2021.12.n1879 (in Russian)
10. Pogosova N.V., Oganov R.G., Boytsov S.A., Ausheva A.K., Sokolova O. Yu., Kursakov A.A., Osipova I.V., Antropova O.N., Pozdnyakov Yu.M., Salbieva A.O., Lelchuk I.N., Gusarova T.A., Gomyranova N.V., Skazin N.A., Kotseva K. Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2020; 19 (6): 2739. DOI: https://doi.org/10.15829/1728-8800-2020-2739 (in Russian)
11. Pogosova N.V., Boytsov S.A., Ausheva A.K., Sokolova O.Y., Arutyunov A.A., Osipova I.V., Pozdnyakov Yu.M. Drug therapy and adherence in patients with coronary heart disease: results of the Russian part of the EUROASPIRE V international multicenter study. Kardiologiia [Cardiology]. 2021; 61 (8): 4–13. DOI: https://doi.org/10.18087/cardio.2021.8.n1650 (in Russian)
12. Zagrebelnyi A.V., Martsevich S. Yu, Luk’ianov M.M., Vorob’ev A.N., Moseichuk K.A., Iakushin S.S., Ershova A.I., Boytsov S.A. Quality of lipid-lowering therapy in outpatient practice: RECVAS Register data. Profilakticheskaya meditsina [Preventive medicine]. 2016; 19 (1): 9–14. DOI: https://doi.org/10.17116/profmed20161919-14 (in Russian)
13. Badran M., Yassin B.A., Fox N. Laher I., Ayas N. Epidemiology of Sleep Disturbances and Cardiovascular Consequences. Can J Cardiol. 2015; 31: 873–9.
14. Sofi F., Cesari F., Casini A., Macchi C., Abbate R., Gensini G.F. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014; 21: 57–64.
15. Ge L., Guyatt G., Tian J., et al. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies. Sleep Med. Rev. 2019; 48: 101–215. DOI: https://doi:10.1016/j.smrv.2019.101215
16. Sateia M.J. International classification of sleep disorders – third edition: highlights and modifications. Chest. 2014; 146 (5): 1387–94. DOI: https://doi.org/10.1378/chest.14-0970
17. Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep. 2007; 30 (2): 213–8. DOI: https://doi.org/10.1093/sleep/30.2.213
18. Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008; 31 (4): 473–80. DOI: https://doi.org/10.1093/sleep/31.4.473
19. Schutte-Rodin S., Broch L., Buysse D., Dorsey C., Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4 (5): 487–504. DOI: https://pubmed.ncbi.nlm.nih.gov/18853708/
20. Aernout E., Benradia I., Hazo J.-B., Sy A., Askevis-Leherpeux F., Sebbane D., Roelandt J.-L. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med. 2021; 82: 186–92. DOI: https://doi.org/10.1016/j.sleep.2021.03.028
21. Li M., Zhang X.W., Hou W.S., Tang Z.Y. Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol. 2014; 176 (3): 1044–7. DOI: https://doi.org/10.1016/j.ijcard.2014.07.284
22. Meng L., Zheng Y., Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res. 2013; 36 (11): 985–95. DOI: https://doi.org/10.1038/hr.2013.70
23. Sofi F., Cesari F., Casini A., Macchi C., Abbate R., Gensini G.F. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014; 21 (1): 57–64. DOI: https://doi.org/10.1177/2047487312460020
24. Laugsand L.E., Vatten L.J., Platou C., Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011; 124 (19): 2073–81. DOI: https://10.1161/CIRCULATIONAHA.111.025858
25. Laugsand L.E., Strand L.B., Platou C., Vatten L.J., Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014; 35 (21): 1382–93. DOI: https://doi.org/10.1093/eurheartj/eht019
26. Palagini L., Bruno R.M., Gemignani A., Baglioni C., Ghiadoni L., Riemann D. Sleep loss and hypertension: a systematic review. Curr Pharm Des. 2013; 19 (13): 2409–19. DOI: https://doi.org/10.2174/1381612811319130009
27. Anothaisintawee T., Reutrakul S., Van Cauter E., Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med. Rev. 2016; 30: 11–24. DOI: https://doi.org/10.1016/j.smrv.2015.10.002
28. Bayon V., Léger D., Gomez-Merino N., Vecchierini M.F., Chennaoui M. Sleep debt and obesity. Ann Med. 2014; 46 (5): 264–72. DOI: https://doi.org/10.3109/07853890.2014.931103
29. Buxton O.M., Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010; 71 (5): 1027–36. DOI: https://doi.org/10.1016/j.socscimed.2010.05.041
30. Cappuccio F.P., D’Elia L., Strazzullo P., Miller M.A. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33 (2): 414–20. DOI: https://doi.org/10.2337/dc09-1124
31. Faraut B., Touchette E., Gamble H., Royant-Parola S., Safar M.E., Varsat B., Léger D. Short sleep duration and increased risk of hypertension: a primary care medicine investigation. J Hypertens. 2012; 30 (7): 1354–63. DOI: https://doi.org/10.1097/HJH.0b013e32835465e5
32. Patel S.R., Hu F.B. Short sleep duration and weight gain: a systematic review. Obesity. 2008; 16 (3): 643–53. DOI: https://doi.org/10.1038/oby.2007.118
33. Liu T.Z., Xu C., Rota M., Cai H., Zhang C., Shi M.J., et al. Sleep duration and risk of all-cause mortality: a flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med Rev. 2017; 32: 28–36. DOI: https://doi.org/10.1016/j.smrv.2016.02.005
34. Guilleminault C., Connolly S.J., Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52: 490–4.
35. Benjafield A.V., Ayas N.T., Eastwood P.R., et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019; 7 (8): 687–98. DOI: https://doi:10.1016/S2213-2600(19)30198-5
36. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2021; 398: 957–80. DOI: https://doi:10.1016/S0140-6736(21)01330-1
37. Balanova Y.A., Shalnova S.A., Imaeva A.E., Kapustina A.V., Muromtseva G.A., Evstifeeva S.E., Tarasov V.I., Redko A.N., Viktorova I.A., Prishchepa N.N., Yakushin S.S., Boytsov S.A., Drapkina O.M. on behalf of ESSE-RF-2 researchers. Prevalence, awareness, treatment and control of hypertension in Russian Federation (Data of Observational ESSE-RF-2 Study). Ratsional’naaya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2019; 15 (4): 450–66. DOI: https://doi.org/10.20996/1819-6446-2019-15-4-450-466 (in Russian)
38. Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V., et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012–2013 years. The results of ECVD-RF study. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2014; 13 (6): 4–11. (in Russian)
39. Balanova Yu.A., Shalnova S.A., Deev A.D., Imaeva A.E., Kontsevaya A.V., Muromtseva G.A., Kapustina А.V., Evstifeeva S.E., Drapkina О.M. Obesity in Russian population – prevalence and association with the non-communicable diseases risk factors. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2018; (6): 123–30. DOI: https://doi.org/10.15829/1560-4071-2018-6-123-130 (in Russian)
40. Zhernakova Yu.V., Zheleznova E.A., Chazova I.E., et al. The prevalence of abdominal obesity and the association with socioeconomic status in Regions of the Russian Federation, the results of the epidemiological study – ESSE-RF. Terapevticheskii arkhiv [Therapeutic Archive]. 2018; 90 (10): 14–22. DOI: https://doi.org/10.26442/terarkh201890104-22 (in Russian)
41. Zhernakova Yu.V., Chazova I.E., Oshchepkova E.V., et al. The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results. Sistemnye gipertenzii [Systemic Hypertension]. 2018; 15 (1): 56–62. DOI: https://doi.org/10.26442/2075-082X_15.1.56-62
42. URL: https://internist.ru/publications/detail/sindrom-obstruktivnogo-apnoe-sna-glazami-kardiologa
43. Smith W.M., Meyers A.D. Obstructive sleep apnea and home sleep monitoring overview of obstructive sleep apnea. 2019. URL: https://emedicine.medscape.com/article/1518830-overview
44. Logan A.G., Perlikowski S.M., Mente A., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001; 19 (12): 2271–7.
45. Dudenbostel T., Calhoun D.A. Resistant hypertension, obstructive sleep apnea and aldosterone. J Hum Hypertens. 2012; 26 (5): 281–7.
46. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the join National committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289 (19): 2560–72.
47. Suzuki M., Guilleminault C., Otsuka K., et al. Blood pressure dipping and non-dipping in OSAS patients. Sleep. 1996; 19: 382–7.
48. Galaktionov D.A. State of the cardiovascular system in patients with obstructive sleep apnea syndrome of varying severity: Abstract of the dissertation – candidate of medical sciences. St. Petersburg, 2017. (in Russian)
49. Litvin A.Y., Chazova I.E. Obstructive sleep apnea syndrome. Sistemnye gipertenzii [Systemic Hypertension]. 2009; (1): 32–41. (in Russian)
50. Chami H.A., Resnick H.E., Quan S.F., et al. Association of incident cardiovascular disease with progression of sleep-disordered breathing. Circulation. 2011; 123 (12): 1280–6.
51. Garcia-Rio F., Alonso-Fernandez A., Armada E., et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. International journal of cardiology. 2013; 168 (2): 1328–35.
52. Medeiros A.K., Coutinho R.Q., Baros I.M., et al. Obstructive sleep apnea is independently associated with subclinical coronary atherosclerosis among middle-aged women. Sleep and breathing. 2016; 9: 281–310.
53. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the sleep heart health study. American journal of respiratory and critical care medicine. 2001; 163 (1): 19–25.
54. Ahmed A.H., Shankar K.J., Eftekhari H. Silent myocardial ischemia: Current perspectives and future directions. Experimental and clinical cardiology. 2007; 12 (4): 189–96.
55. Goncharov A.P., Volov N.A., Shaydyuk O. Yu. Obstructive sleep apnoea syndrome in patients with functional class IV effort angina. Russian Rossiysliy kardiologicheskiy zhurnal [Journal of Cardiology]. 2010; (1): 18–23. (in Russian)
56. Franclin K.A., Nilsson J.B., Sahlin C., et al. Sleep apnea and nocturnal angina. Lancet. 1996; 345 (8957): 1341–5.
57. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006; 173: 910–16.
58. Cintra F.D., Leite R.P., Storti L.J., et al. Sleep apnea and nocturnal cardiac arrhythmia: a populational study. Arq Bras Cardiol. 2014; 103: 368–74.
59. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006; 173: 910–6.
60. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007; 49: 565–71.
61. Matiello M., Nadal M., Tamborero D., et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010; 12: 1084–9.
62. Fein A.S., Shvilkin A., Shah D., et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013; 62: 300–5.
63. Li L., Wang Z.W., Li J., et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014; 16: 1309–14.
64. Salari N., et al. The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis. Neurological Sciences. 2021; 1. DOI: https://doi.org/10.1007/s10072-021-05765-3
65. Klar Y.H., et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005; 353: 2034–41. DOI: https://doi.org/10.1056/NEJMoa043104
66. Tong J., Yu Q., Li Y., et al. Obstructive sleep apnea and cardiovascular events in acute coronary syndrome: a meta-analysis. Coron Artery Dis. 2023; 34 (3): 177–84. DOI: https://doi:10.1097/MCA.0000000000001207
67. Brisco M.A., Goldberg L.K. Sleep apnea in congestive heart failure. Current heart failure reports. 2010; 7: 175–84.
68. Kahwash R., Kahwash G., Yenokyan A.B. Newman Recognition and management of sleep disorders breathing in chronic heart failure. Current heart failure reports. 2011; 8: 72–9.
69. Abdelsattar Z.M., Hendren S., Wong S.L., et al. The impact of untreated obstructive sleep apnea on cardiopulmonary complications in general and vascular surgery: a cohort study. Sleep. 2015; 38: 1205–10.
70. Kaw R., Chung F., Pasupuleti V., et al. Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome. Br J Anesth. 2012; 109: 897–906.
71. Memtsoudis S., Liu S.S., Ma Y., Chiu Y.L., Walz J.M., Gaber-Baylis L.K., Mazumdar M. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg. 2011; 112: 113–21.
72. Roesslein M., Chung F. Obstructive sleep apnoea in adults: peri-operative considerations. A narrative review. Eur J Anaesthesiol. 2018; 35: 245–255.
73. Kim J.A., Lee J.J. Preoperative predictors of difficult intubation in patients with obstructive sleep apnea syndrome. Can J Anesth. 2006; 53 (4): 393–7.
74. Abdelsattar Z.M., Hendren S., Wong S.L., et al. The impact of untreated obstructive sleep apnea on cardiopulmonary complications in general and vascular surgery: a cohort study. Sleep. 2015; 38: 1205–10.
75. Jonsson Fagerlund M., Franklin K.A. Perioperative continuous positive airway pressure therapy: a review with the emphasis on randomized controlled trials and obstructive sleep apnea. 2021; 132 (5): 1306–13.
76. Benjafield A.V., et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine. 2019; 7 (8): 687–98.
77. Memtsoudis S.G., Besculides M.C., Mazumdar M. A rude awakening-the perioperative sleep apnea epidemic. N Engl J. Med. 2013; 368: 2352–3.
78. Adesanya A.O., Lee W., Greilich N.B., Joshi G.P. Perioperative management of obstructive sleep apnea. Chest. 2010; 138: 1489–98.
79. Senthilvel E., Auckley D., Dasarathy J. Evaluation of sleep disorders in the primary care setting: history taking compared to questionnaires. J Clin Sleep Med. 2011; 7 (1): 41–8.
80. Babak S.L., Gorbunova M.V. Obstructive sleep apnea syndrome in the clinical practice of a therapist. Doktor.Ru [Doctor.Ru]. 2014; 2: 63–71. (in Russian)